全文获取类型
收费全文 | 1181298篇 |
免费 | 74876篇 |
国内免费 | 4232篇 |
学科分类
医药卫生 | 1260406篇 |
出版年
2021年 | 8800篇 |
2019年 | 8914篇 |
2018年 | 14231篇 |
2017年 | 11049篇 |
2016年 | 12703篇 |
2015年 | 14196篇 |
2014年 | 18503篇 |
2013年 | 26531篇 |
2012年 | 36535篇 |
2011年 | 37248篇 |
2010年 | 22177篇 |
2009年 | 20317篇 |
2008年 | 34944篇 |
2007年 | 38017篇 |
2006年 | 38250篇 |
2005年 | 36485篇 |
2004年 | 35207篇 |
2003年 | 33860篇 |
2002年 | 32996篇 |
2001年 | 64325篇 |
2000年 | 65500篇 |
1999年 | 54241篇 |
1998年 | 13714篇 |
1997年 | 11420篇 |
1996年 | 11021篇 |
1995年 | 10258篇 |
1994年 | 9373篇 |
1993年 | 8638篇 |
1992年 | 38441篇 |
1991年 | 37388篇 |
1990年 | 36212篇 |
1989年 | 35724篇 |
1988年 | 32257篇 |
1987年 | 31281篇 |
1986年 | 29438篇 |
1985年 | 27500篇 |
1984年 | 19765篇 |
1983年 | 16535篇 |
1982年 | 8942篇 |
1979年 | 17591篇 |
1978年 | 12052篇 |
1977年 | 10257篇 |
1976年 | 9270篇 |
1975年 | 10677篇 |
1974年 | 12338篇 |
1973年 | 11727篇 |
1972年 | 11181篇 |
1971年 | 10616篇 |
1970年 | 10064篇 |
1969年 | 9428篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Published data devoted to making and characterization of the properties of polymeric wound dressings with proteolytic action
are reviewed. These data are indicative of individual dependence of the physicochemical properties, activity, and stability
of each particular enzyme on the type of polymer matrix and the method of immobilization. In order to obtain wound dressings,
which are active in physiological medium and retain their activity upon sterilization, it is necessary to optimize the composition
and characteristics of a polymer matrix and the enzyme included into its structure.
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 40, No. 8, pp. 24–28, August, 2006. 相似文献
52.
Ohne Zusammenfassung 相似文献
53.
54.
R H Green C E Brightling S McKenna B Hargadon N Neale D Parker C Ruse I P Hall I D Pavord 《The European respiratory journal》2006,27(6):1144-1151
There is increasing evidence that the assessment of eosinophilic airway inflammation using induced sputum and measurement of airway hyperresponsiveness provides additional, clinically important information concerning asthma control. The aim of this study was to directly compare the effects of different treatments on these markers in patients with asthma and persistent symptoms, despite the use of low-dose inhaled corticosteroids. A double-blind four-way crossover study was performed, which compared a 1-month treatment with budesonide 400 mug b.i.d., additional formoterol, additional montelukast and placebo in 49 patients with uncontrolled asthma despite budesonide 100 mug b.i.d., with each treatment separated by a 4-week washout period. The change in sputum eosinophil count with formoterol (2.4 to 3.8% change, 0.6-fold reduction, 95% confidence interval (CI) 0.5-0.9) differed significantly from placebo (2.8 to 2.5% change, 1.1-fold reduction, 95% CI 0.7-1.6) and high-dose budesonide (2.7 to 1.6% change, 1.6-fold reduction, 95% CI 1.2-2.2). The effects of montelukast did not differ from placebo. The changes in methacholine airway responsiveness were small and did not differ between treatments. High-dose budesonide had the broadest range of beneficial effects on other outcomes, including symptom scores, morning peak expiratory flow and forced expiratory volume in one second. In conclusion, treatment given in addition to low-dose inhaled corticosteroids results in modest benefits. Formoterol and high-dose budesonide have contrasting effects on eosinophilic airway inflammation. 相似文献
55.
J Müller-Quernheim K I Gaede E Fireman G Zissel 《The European respiratory journal》2006,27(6):1190-1195
An increase in chronic beryllium disease (CBD) has been suggested due to higher industrial use of beryllium alloys. Since occupational CBD is a perfect phenocopy of sarcoidosis, it might be misdiagnosed as sarcoidosis. In the current it was hypothesised that CBD exists in cohorts of sarcoidosis patients. In a prospective case study, sarcoidosis patients were evaluated for potential beryllium exposure. In those patients in whom beryllium exposure was confirmed and beryllium hypersensitivity demonstrated, the diagnosis of sarcoidosis was rejected and corrected to CBD. In 84 patients seen for re-evaluation or making a diagnosis of sarcoidosis, beryllium exposure was recognised and a diagnosis of CBD was made in 34 out of 84 patients. The time lag between clinical diagnosis of sarcoidosis and the final diagnosis of CBD ranged 0-18 yrs (median 3 yrs) and the mean (range) age at time of diagnosis of CBD was 43.9(25-80) yrs. Beryllium-contaminated workplaces causing disease encompassed a wide spectrum of industries and technical trades in which beryllium-exposure is generally not perceived as a health hazard. In conclusion, chronic beryllium disease still belongs to the spectrum of differential diagnoses of granulomatous disorders. 相似文献
56.
N B Pride 《The European respiratory journal》2006,27(1):240-1; author reply 241-2
57.
58.
59.
Chan C. H. Y Ng E. H. Y Chan C. L W 《世界核心医学期刊文摘》2006,2(6):15-15
目的:评价东部身体-智力-精神(EBMS)群体干预对进行体外受精(IVF)的中国妇女焦虑缓解的作用。设计:随机对照研究。机构:三级辅助生殖机构。受试者:227例接受第1个IVF周期治疗的妇女。干预:干预组(n=69)接受4次EBMS群体咨询,而对照组(n=115)无任何干预。主要观察指标:状态-特质焦虑问卷。结果:与对照组相比,干预组在干预后状态焦虑平均分显著下降。每组移植同样数目的卵子,但干预组没有明显更高妊娠率的倾向。 相似文献
60.